Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Genetic profiling of extended-spectrum β-Lactamase and carbapenemase-producing Escherichia coli O157:H7 from clinical samples among diarrheal patients in Shashemene, Ethiopia

Abstract

Background

Escherichia coli (E. coli) O157:H7, associated with diarrhea, poses a global health risk. In Ethiopia, where diarrhea is common, there is limited knowledge about these resistant strains and a lack of data on Extended-Spectrum β-Lactamase (ESBL) and carbapenemase production. Understanding the prevalence of antimicrobial resistance genes associated with ESBL and carbapenems is crucial for addressing diarrheal disease. This study aimed to investigate the genetic profile of ESBL and carbapenemase coding gene carriage in E. coli O157:H7 from clinical stool samples and evaluate antimicrobial susceptibility patterns.

Methods

A total of twenty-nine bacterial isolates obtained from diarrheal patients were subjected to conventional culture and phenotypic (Kirby Bauer disc diffusion method) testing for antimicrobial resistance. Additionally, screening for the production of ESBL (combined disk method) and carbapenemase (modified carbapenem inactivation method) was conducted. Isolates that tested positive for ESBL and carbapenemase production were further analyzed, targeting five genes (blaNDM, blaKPC, blaCTX−M, blaTEM, and blaSHV) associated with ESBL and carbapenemase production. Data analysis was performed using SPSS version 27.0, employing logistic regression and descriptive statistics.

Results

We analyzed a total of 27 isolates that were ESBL-positive and 12 isolates that were found to produce carbapenemase phenotypically. These isolates were obtained from clinical stool samples and (9/27) 33.3% of the isolates were from under five years children, predominantly from urban areas, and those that have contact with domestic animals. Genes coding ESBL were found in (19/27) 70.4% of the isolates, the most predominant being blaCTX−M and blaTEM. Eight isolates carried blaKPC, but none had blaNDM, while five isolates carried both blaCTX−M and blaTEM genes. blaSHV-carrying isolates showed phenotypic resistance to ampicillin and cephalosporins, while blaKPC-carrying isolates exhibited resistance to ampicillin, carbapenems, and tetracycline.

Conclusion

This study identifies a significant prevalence of multidrug resistance in E. coli O157:H7, which can be attributed to the presence of resistance genes coding for ESBL and carbapenem production. Key factors contributing to this resistance, such as urban environments, children under the age of five, and domestic animal ownership, have been emphasized. Additionally, this research underscores the urgent need for enhanced surveillance and targeted interventions to address this pressing public health concern.

Peer Review reports

Introduction

Antibiotic resistance (AMR) in bacterial pathogens poses a significant global public health threat [1]. Escherichia coli (E. coli) O157:H7, a strain known to cause diarrheal illnesses, has exhibited a concerning increase in antibiotic resistance, including extended-spectrum-lactamases (ESBLs) and carbapenemases production [2,3,4]. Even though the administration of antimicrobial is not recommended for treating E. coli O157:H7 infection due to the exacerbation of the clinical condition caused by lysis of the bacteria and subsequent release of Shiga-like toxins [5, 6], The antibiotic resistance pattern of this strain is a matter of public health concern. This is because it has the potential to horizontally transfer resistance genes through conjugation to the normal microbiota or opportunistic pathogens in the gut [7]. This resistance profile significantly limits the effectiveness of conventional antimicrobial, resulting in treatment failures and higher rates of morbidity and mortality [8].

Ethiopia is widely recognized for its substantial burden of diarrheal illnesses, which contribute to elevated rates of morbidity and mortality, particularly among vulnerable populations [9]. However, there exists a dearth of knowledge regarding the prevalence of ESBL and carbapenemase production in E. coli O157:H7 strains within this study setting [10, 11].

Consequently, the primary objective of this investigation is to rectify this knowledge gap by undertaking a comprehensive analysis of the genetic composition of E. coli O157:H7 strains. These strains were sourced from clinical samples obtained from individuals with diarrhea and were tested to ascertain the presence of genes responsible for ESBL and carbapenemase production.

The findings of this study will contribute valuable insights into the presence and prevalence of specific gene responsible for production of ESBL and carbapenemase in E. coli O157:H7 strains in Ethiopia. This data holds significant potential for informing the development of effective infection control measures and promoting antimicrobial stewardship programs. By providing clinicians with scientific evidence, this research can empower them to design treatment regimens based on evidence-based practices, consequently leading to a substantial reduction in the spread of antibiotic-resistant bacteria and improving patient outcomes in cases of diarrheal illnesses.

Methods and materials

Study site and sampling

This study was conducted in Shashemene Town and Shashemene Zuria Woreda under the Ethiopian Cholera Control and Prevention (ECCP) project as section of master thesis project. Eight public primary healthcare facilities (HCFs) found in Shashemene town (Abosto, Awasho, Chebi, Toga, Harbate, Fajogole health centers as well as Melka oda and Shashemene specialized hospitals) were included in this study randomly. Diarrheal stool samples collection and culturing were done from July 2022 to November 2022 and all sample with phenotypically confirmed ESBL and carbapenemase producing E.coli O157:H7 isolates were included in the study.

Bacterial isolation and identification of isolates

All lactose fermenting bacterial isolates suspected to E. coli from MacConkey agar (Condalab, Spain) were identified by running API 20E (Biomerieux, France) biochemical tests. Further identification of the serotype E. coli O157:H7 was done using sorbitol (Condalab, Spain) utilization and O157 antisera (Denka, Japan).

Antimicrobial susceptibility testing

Isolated colonies were phenotypically tested against 15 antimicrobials (Ampicillin (10 µg), Amoxicillin-clavulanate (20/10 µg), Gentamicin (10 µg), Ceftriaxone (30 µg), Cefotaxime (30 µg), Ceftazidime (30 µg), Ciprofloxacin (5 µg), Trimethoprim-Sulfamethoxazole (1.25/23.75 µg), Chloramphenicol (30 µg), Azithromycin (15 µg), Cefuroxime (30 µg), Tetracycline (30 µg), Imipenem(10 µg), Ertapenem (10 µg), and Meropenem(10 µg) (all produced by Condalab, Spain), using the Kirby–Bauer disc diffusion method for the presence of resistance.

Multidrug resistance Bacteria

Based on CLSI guidelines, we have classified E. coli O157:H7 isolates as multidrug resistant (MDR) if they demonstrate non-susceptibility to more than one class of antimicrobials.

ESBL and carbapenemase production

Production of ESBL (combined disk method using cefotaxime, ceftriaxone, and ceftazidime in combination with clavulanic acid) and carbapenemase (modified carbapenem inactivation method using 10-µg meropenem disk) was determined as instructed by CLSI guideline [12]. All ESBL- and carbapenemase-positive isolates were tested for the presence of ESBL and carbapenemase target genes.

Molecular characterization of ESBLs and carbapenemase genes

DNA extraction

The DNA was extracted from fresh colonies of E. coli O157:H7 isolates by the boiling method according to Dashti et al. [13]. Three to five colonies of an overnight growth of each isolate on nutrient agar (Oxoid, UK) were suspended in 500 µL of 1x Tris-acetate-EDTA (TAE) buffer (Sigma, Germany). The suspension was boiled at 94 °C for 15 min in a water bath (Thermo-fisher Scientific, California) and placed in a freezer at − 20 °C for 10 min, then placed at room temperature for one minute and centrifuged at 13,000 g for 5 min. Finally, 150 µL of the supernatant was transferred into a nuclease-free Eppendorf tube and checked for quality and quantity of DNA using gel electrophoresis (After performing gel electrophoresis, the concentration and yield are determined by comparing the intensity of the DNA sample with a DNA quantitation standard. In particular, if a 2 µl sample of undiluted DNA shows a similar intensity to the 100ng standard, the concentration can be calculated as 50ng/µl (obtained by dividing 100ng by 2 µl) [14].) before storage at − 20 °C until analysis.

PCR protocol

ESBL genes (blaCTX−M group, blaTEM group, and blaSHV group) and carbapenem resistance-determining genes (blaKPC group and blaNDM group) were detected using conventional PCR method by utilizing primer pairs listed below. (Table 1.)

Table 1 Sequence of primers used in detecting the ESBL and carbapenemase genes

Detection of ESBL genes was performed in one PCR reaction by multiplexing the above three ESBL genes in one reaction tube. Detection of carbapenemase genes was performed in two separate uniplex PCR reactions with two separate reaction tubes. For both ESBL and carbapenemase genes, the PCR was performed in the MJ Mini PTC-1148 thermocycler (Bio-Rad, USA) in a final volume of 25 µL containing 12.5 µL 2 x Hot Star Taq multiplex PCR Master Mix (QIAGEN, Netherland), 1 µL of each primer (2 µM), 2 µL of template DNA, and 8.5 µL of nuclease-free water, in accordance to previously published protocol [15]. The PCR cycling parameters for both reactions were: initial denaturation at 95 °C for 15 min followed by 35 cycles each of denaturation at 94 °C for 30s, annealing at 58 °C for 90s, extension at 72 °C for 90s, and final extension at 72 °C for 10 min. The PCR products were visualized by performing gel-electrophoresis in 1.5% agarose gel after staining in ethidium bromide with the aid of a gel imaging system, GelDoc (Cleaver GelPro). A 100 bp ladder molecular weight marker (Promega-cat no. 15628019) was used to measure the molecular weight of amplified products.

Quality control

A positive American Type Culture Collection (ATCC) was utilized to validate the efficacy of each culture medium employed. Furthermore, during each phase of the confirmatory testing for ESBL and carbapenemases, both positive and negative controls were incorporated. The positive controls included K. pneumoniae ATCC 700,603 for ESBL and K. pneumoniae ATCC 1705 for carbapenemase, while E. coli ATCC 25,922 served as the negative control for both throughout the process.

Data management and statistical analysis

The data were coded and entered into the SPSS version 27.0 software for analysis. Categorical covariates were summarized using frequencies and percentages. Logistic regression and descriptive statistics was employed to investigate the association between antimicrobial resistance and the carried gene with 95% CI (p-value < 0.005).

Results

General characteristics

A total of 29 phenotypically confirmed (16 ESBL, 1 carbapenemase-producing and 11 both ESBL and carbapenemase-producing) isolates were used for this molecular characterization. The majority of the study participants with ESBL and carbapenemase-positive isolates were males (18/29) with male to female ratio of 1.6:1. Nine of the 27 (33.33%) participants with phenotypic ESBL and five of the 12 (41.67%) carbapenemase-producing isolates were < 5 years of age. The majority of participants with isolates that harbored only ESBL genes (15/19) and all 5 isolates that carried both ESBL and carbapenemase genes were from urban areas. All participants infected with ESBL and carbapenemase gene-carrying E. coli o157:H7 owned domestic animals.

ESBL and carbapenemase coding gene carriage

There were 27 isolates phenotypically confirmed to produce ESBL and all these isolates were tested for the presence of the three most common genes of ESBL (blaCTX−M group, blaTEM group, and blaSHV group) (Table 2). Of these ESBL-positive isolates, 19 (70.4%) were confirmed to carry at least one of the ESBL coding genes. Three of these isolates possessed only blaCTX−M gene, 6 of them carried blaTEM only, and eight isolates possessed both blaCTX−M and blaTEM genes, whereas one isolate had all the three genes. There were eight isolates genotypically verified to be carbapenemase producers, and all of them harbored the blaKPC gene but not the blaNDM gene. Furthermore, four isolates had the blaCTX−M, blaTEM, and blaKPC genes, among the five isolates verified to have had both ESBL and carbapenemase coding genes. (Fig. 1.)

Fig. 1
figure 1

Gel image of the ESBL and carbapenemase genes from E. coli O157:H7 isolates (A-Gel image for ESBL gene PCR amplification, B-Gel image for carbapenemase gene PCR amplification)

ESBL and carbapenemase co-production

Out of the twenty nine ESBL-producing isolates, 10 (34,5%) were both ESBL and carbapenemase producers phenotypically, of which 50% (5/10) isolates were confirmed to have both ESBL and carbapenemase coding genes (80% (4/5) isolates produced blaCTX−M, blaTEM, and blaKPC; but only 20% (1/5) isolate produced blaTEM, and blaKPC) (Table 2).

Table 2 Frequency of isolates harboring ESBL and carbapenemase-encoding genes

Antimicrobial resistance status of ESBL and carbapenemase-producing isolates with respect to the presence of specific genes

Antimicrobial resistance was tested against isolates encoding the ESBL (blaCTX−M, blaSHV, and blaTEM) and carbapenemase (blaKPC) genes. Resistance to ampicillin, amoxicillin with clavulanic acid, and certain carbapenems was observed in a small number of isolates bearing solely the blaCTX−M; and resistance to ampicillin, amoxicillin with clavulanic acid, cephalosporins, and carbapenems were observed in isolates containing both the blaCTX−M and blaTEM genes. The blaSHV gene-carrying isolates were resistant to ampicillin and cephalosporins but susceptible to carbapenems. All isolates carrying the blaKPC gene were resistant to ampicillin, carbapenems, and, in many cases, tetracycline. (Fig. 2.)

Fig. 2
figure 2

Frequencies of Antimicrobial-resistant ESBL and carbapenemase-producing isolates with respect to the presence of specific genes

Discussion

The rise and spread of multidrug-resistant bacteria, particularly those that produce extended-spectrum beta-lactamases (ESBLs) and carbapenemases, pose a danger to global public health. In this work, we wanted to look at the molecular profiles of ESBL and carbapenemase-producing isolates from E. coli O157:H7 isolates obtained from a cohort of participants.

Our findings indicate a high prevalence of ESBL production among the isolates, with nearly one-third demonstrating the ability to produce carbapenemase. This is a critical discovery, as it shows that a significant portion of the E. coli O157 isolates carry and express genes linked to ESBLs and carbapenemases, both of which contribute to antibiotic resistance. This presents a major challenge for treatment, as infections caused by these resistant strains are more difficult to manage.

Among the three groups of genes analyzed in our study, the blaTEM group was found to be the most prevalent, followed by the blaCTX−M group. This finding emphasizes the wide range of beta-lactam antibiotic resistance, which includes resistance to penicillins, cephalosporins, and aztreonam. Furthermore, this discovery reveals the potential for horizontal gene transfer of the TEM and CTX-M genes to various bacterial species. This is a matter of great concern, as both genes are frequently located on plasmids, enabling their transfer between different bacteria. This finding is in agreement with the study from Egypt [18] where the blaTEM gene group was predominant from E. coli in general without selecting for specific strains. However, our finding is in disagreement with reports from studies conducted among E. coli isolates from Portugal [19], Ethiopia [15], and Lebanon [4], where the majority of isolates were shown to carry the blaCTX−M group gene rather than blaTEM group as well as India [20], where it was blaSHV is predominantly detected gene group. This discrepancy could be because of difference in environmental, carrier host, human migration, sanitation and animal feeding habit difference in different areas [21].

Twelve (31.6%) isolates from the total of 38 E. coli O157:H7 were phenotypically confirmed to produce carbapenemase and, therefore, were tested for the presence of the two most common genes of carbapenemase (blaKPC group and blaNDM group). Out of these 12 isolates, 8 (66.6%) were confirmed to have the blaKPC group gene which is in agreement with the finding from the previously mentioned study in Egypt [18]. However, it was different from a study finding India [22] that reported blaNDM group to be the predominant one rather than blaKPC gene group. In contrast, none of the isolates in our study was positive for the blaNDM gene group. Furthermore, some isolates harbored both ESBL and carbapenemase genes, exhibiting different combinations of blaCTX−M, blaTEM, and blaKPC genes.

The difference in distribution of ESBL and carbapenemase coding genes could be due to the influence of several factors, including geographical variations, horizontal gene transfer, antibiotic usage, sanitation and hygiene practices, animal husbandry practices, human migration, and differences in study design [4, 10]. These factors could be possible contributors to the observed discrepancies between our study and others from different regions, highlighting the complex interplay of environmental, healthcare, and social factors in the spread of antibiotic resistance [19, 23, 24]. Understanding these influences is crucial for developing targeted strategies to combat antibiotic resistance in various regions.

Our finding also showed different patterns of phenotypic resistance in association with the presence of specific genes as among isolates bearing blaCTX−M, blaTEM, blaSHV, and blaKPC. The isolates possessing both blaCTX−M and blaTEM genes exhibited a broader resistance profile, including resistance to ampicillin, amoxicillin with clavulanic acid, cephalosporins, and carbapenems. On the other hand, isolates that carry blaSHV gene showed resistance to ampicillin and cephalosporins but were susceptible to carbapenems. All isolates that harbored blaKPC gene showed resistance to ampicillin, carbapenems, and often tetracycline. The presence of these specific resistance genes in bacterial isolates can have significant clinical and public health implications. These genes are associated with heavy burden of resistance against commonly used antibiotic, which can complicate both individual treatment options and broader public health strategies. Understanding these genetic markers is vital for tailored treatment strategies, guiding antibiotic prescriptions, and public health interventions to mitigate antibiotic resistance [25].

Another distribution observation in this study was that a high proportion of ESBL and carbapenemase-positive isolates were detected from children under the age of five, where 9 participants carried ESBL-producing isolates while 5 carries carbapenemase-producing isolates. This detection showcases the need for monitoring antibiotic resistance in the pediatric populations since it has consequences for infection management in this vulnerable age group [26, 27].

In terms of geographical distribution, our study found that the majority of individuals with ESBL gene-positive isolates (15 out of 19) were from urban regions, as were all participants with isolates carrying both ESBL and carbapenemase genes. This finding reveals a possible link between urbanization and the occurrence of antibiotic resistance. Cities with high population density and increased antibiotic use may provide favorable conditions for the spread of resistant microorganisms [28, 29].

Furthermore, among people infected with ESBL and carbapenemase gene-carrying E. coli O157:H7, there was a high association between the presence of ESBL genes and the ownership of domestic animals. This observation is consistent with earlier research report that identified animals, particularly livestock, as repositories of antibiotic-resistant bacteria and potential sites of transmission to people [30, 31].

Conclusion and recommendations

Our study underscores the concerning prevalence of multidrug resistant E. coli O157:H7 isolates, with a substantial proportion ESBL and carbapenemase production. The predominance of blaTEM and blaKPC genes highlights the genetic diversity that contributes to antimicrobial resistance. The co-occurrence of ESBL and carbapenemase genes, particularly in urban areas and among children under five years of age, indicates a pressing need for area-specific antibiotic stewardship programs. Furthermore, the association between resistant isolates and domestic animal ownership underscores the significance of zoonotic transmission. We would like to advocate for enhanced surveillance of resistance genes, the implementation of stricter antibiotic usage policies, public education on hygiene practices, and targeted interventions for high-risk groups, including pediatric populations and urban communities.

Limitation of the study

We exclusively performed a molecular test that targeted five particular genes. Nevertheless, an epidemiological trace back to ascertain the origin of resistance in positive isolates was not carried out. Regrettably, this can be attributed to insufficient resources.

Data availability

The datasets produced and/or analyzed during the ongoing study can be obtained from the corresponding authors upon a reasonable request.

References

  1. WHO. Antibiotic resistance Fact Sheet. 2020 [cited 2023 05.07]; Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance

  2. Abebe E, et al. Occurrence and antimicrobial resistance pattern of E. Coli O157: H7 isolated from foods of bovine origin in Dessie and Kombolcha towns, Ethiopia. PLoS Negl Trop Dis. 2023;17(1):e0010706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gugsa G, et al. Isolation, characterization, and antimicrobial susceptibility pattern of Escherichia coli O157: H7 from foods of bovine origin in Mekelle, Tigray, Ethiopia. Front Veterinary Sci. 2022;9:924736.

    Article  Google Scholar 

  4. Amrieh S et al. Detection of Escherichia coli O157: H7 and O104: H4 in patients with diarrhea in Northern Lebanon and characterization of fecal E. Coli producing ESBL and carbapenemase genes. Int Arabic J Antimicrob Agents, 2014. 4(3).

  5. Smith KE, et al. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr Infect Dis J. 2012;31(1):37–41.

    Article  PubMed  Google Scholar 

  6. Mir RA et al. Supershed Escherichia coli O157: H7 has potential for increased persistence on the rectoanal junction squamous epithelial cells and antibiotic resistance. International Journal of Microbiology, 2020. 2020.

  7. Warnes SL, Highmore CJ, Keevil CW. Horizontal transfer of antibiotic resistance genes on abiotic touch surfaces: implications for public health. MBio. 2012;3(6). https://doi.org/10.1128/mbio. 00489– 12.

  8. Dhingra S, et al. Microbial resistance movements: an overview of global public health threats posed by antimicrobial resistance, and how best to counter. Front Public Health. 2020;8:535668.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Gessese GT et al. Diarrheal Disease incidence and Associated Mortality in Ethiopia: a systematic subnational analysis in Global Burden of Disease Study, 1990–2019. Ethiop J Health Dev, 2023. 37(2).

  10. Abayneh M, et al. Assessment of extended-spectrum β-lactamase (ESBLs) - producing Escherichia coli from minced meat of cattle and swab samples and hygienic status of meat retailer shops in Jimma town, Southwest Ethiopia. BMC Infect Dis. 2019;19(1):897.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Abreham S, et al. Escherichia coli O157:H7: distribution, molecular characterization, antimicrobial resistance patterns and source of contamination of sheep and goat carcasses at an export abattoir, Mojdo, Ethiopia. BMC Microbiol. 2019;19(1):215.

    Article  PubMed  PubMed Central  Google Scholar 

  12. CLSI. M100-Performance standards for antimicrobial susceptibility testing 2022. p. 152.

  13. Dashti AA, et al. Heat treatment of Bacteria: a simple method of DNA extraction for molecular techniques. Kuwait Med J. 2009;41(2):117–22.

    Google Scholar 

  14. Promega. How do I determine the concentration, yield and purity of a DNA sample? [cited 2024; Available from: https://rb.gy/wu115y

  15. Seman A, et al. Prevalence and molecular characterization of Extended Spectrum β-Lactamase and carbapenemase-producing Enterobacteriaceae isolates from bloodstream infection suspected patients in Addis Ababa, Ethiopia. Infect Drug Resist. 2022;15:1367–82.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Mohammed Y, et al. Characterization of extended-spectrum beta-lactamase from Escherichia coli and Klebsiella species from North Eastern Nigeria. J Clin Diagn Res. 2016;10(2):Dc07–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Poirel L, et al. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–23.

    Article  CAS  PubMed  Google Scholar 

  18. El-Shaer S, et al. Genetic characterization of extended-spectrum β-Lactamase-and carbapenemase-producing Escherichia coli isolated from Egyptian hospitals and environments. PLoS ONE. 2021;16(7):e0255219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Freire S, et al. ESBL-and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among bivalves from Portuguese shellfish production areas. Microorganisms. 2023;11(2):415.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Puii LH, et al. Extended spectrum beta-lactamase producing shiga-toxin producing-Escherichia coli in piglets, humans and water sources in North East region of India. Lett Appl Microbiol. 2019;69(5):373–8.

    Article  CAS  PubMed  Google Scholar 

  21. Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72(8):2145–55.

    Article  CAS  PubMed  Google Scholar 

  22. Manohar P, et al. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India. J Med Microbiol. 2017;66(7):874–83.

    Article  CAS  PubMed  Google Scholar 

  23. Mandakini R, et al. ESBL-producing Shiga-toxigenic E. Coli (STEC) associated with piglet diarrhoea in India. Trop Anim Health Prod. 2015;47(2):377–81.

    Article  PubMed  Google Scholar 

  24. Verschuuren TD, et al. Comparative genomics of ESBL-producing Escherichia coli (ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-intestinal infection isolates in the Netherlands (2014-17). J Antimicrob Chemother. 2021;76(4):901–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Mohammedkheir MI, Gaafar EM, AbdAlla EGE. Genes of Antibiotic Resistance in Gram-Negative Bacilli causing Urinary Tract Infections in Khartoum State: A Cross-sectional study. 2023.

  26. Gerber JS et al. Antibiotic stewardship in pediatrics. Pediatrics, 2021. 147(1).

  27. Donà D, et al. Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review. Antimicrob Resist Infect Control. 2020;9:1–12.

    Google Scholar 

  28. Chandler CI, Nayiga S. Antimicrobial resistance in cities: an overlooked challenge that requires a multidisciplinary approach. Lancet. 2023;401(10377):627–9.

    Article  PubMed  Google Scholar 

  29. Winglee K, et al. Recent urbanization in China is correlated with a westernized microbiome encoding increased virulence and antibiotic resistance genes. Microbiome. 2017;5(1):1–13.

    Article  Google Scholar 

  30. Yuan W, et al. Distribution of antibiotic resistance genes from human and animal origins to their receiving environments: a regional scale survey of urban settings. Environ Pollut. 2022;293:118512.

    Article  CAS  PubMed  Google Scholar 

  31. Spellberg B, et al. Antibiotic resistance in humans and animals. NAM Perspectives; 2016.

Download references

Acknowledgements

The authors would like to thank all participating healthcare facilities for their unreserved support in data collection. Our deepest gratitude also goes to our friends for their scrupulous advice from the selection of the research topic to finalizing this research. We would like to thank Mr. Jemal Hassen for his unreserved support of data analysis.

Funding

This study was supported by the Korea Support Committee (KSC) to International Vaccine Institute (IVI), the LG Electronics and Addis Ababa University. The findings and conclusions are our own and do not necessarily reflect the positions of donors. The IVI acknowledges its donors, including the Government of Republic of Korea and the Swedish International Development Cooperation Agency.

Author information

Authors and Affiliations

Authors

Contributions

S.T.A. was the principal investigator who conceptualized the study and was actively engaged in data collection, laboratory analysis, data interpretation, manuscript drafting, and editing. B.Y.B. and A.A.W. significantly contributed to the laboratory investigation, data interpretation, and data collection. W.E.A., S.G., S.P., Y.J., M.T., and S.T. provided substantial input in the study design, critically reviewed the manuscript, and contributed valuable intellectual content. All authors have read and approved the final version of the manuscript for publication.

Corresponding author

Correspondence to Shimelis Teshome Ayalneh.

Ethics declarations

Ethics approval and consent to participate

This study was approved by Departmental Research Ethics Review Committee (DRERC) of the Department of Microbiology, Immunology & Parasitology (DMIP), College of health science, Addis Ababa University (EC approval document number DRERC/002/2022) and AHRI/ALERT Ethics Review Committee of Armauer Hansen Research Institute (EC approval document number PO/11/21). The ECCP study was approved by the IVI Institutional Review Board (IRB), Seoul, Korea (IRB no. 2021-005); the AHRI/ALERT Ethics Review Committee, Addis Ababa, Ethiopia (approval letter dated 28 July 2021; form AF-10-015); Ethiopian National Research Ethics Review Committee, Addis Ababa, Ethiopia (approval letter dated 17 December 2021; reference no. 7/2-512/m259/35); Oromia Region Health Bureau (Oromia Health Research Directorate approval letter dated 26 August 2021; reference no. REF/UBTU/516/10239). Data were used only for this study purpose. Informed written consent was taken from each study participant and informed consent to participate was obtained from the parents or legal guardians of the participant under the age of 16 following standard ethical procedure as indicated in declaration of Helsinki before recruiting them into the study. Anonymity was maintained during data collection and use of data.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Abbreviations

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ayalneh, S.T., Beshah, B.Y., Jeon, Y. et al. Genetic profiling of extended-spectrum β-Lactamase and carbapenemase-producing Escherichia coli O157:H7 from clinical samples among diarrheal patients in Shashemene, Ethiopia. BMC Infect Dis 25, 90 (2025). https://doi.org/10.1186/s12879-025-10513-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-025-10513-5

Keywords